Genetic testing was most frequently reported for HH (58%); inherited susceptibility to cancer (15%); thrombophilia - Factor V Leiden and/ or prothrombin gene variants affecting function (9%); cardiovascular conditions (5%); neurodegenerative conditions (4%); and neuromuscular conditions (3%). This evidence concerns the gene F2 and cancer.